# The National Treatment Agency (Abolition) and the Health and Social Care Act 2012 (Consequential, Transitional and Saving Provisions) Order 2013, Paragraph 15: Continuing validity of nominations


The amendments made by paragraph 66(1) and (2) of Schedule 2 do not affect the continuation of any person's nomination as a legal representative for the purposes of Schedule 1 to the Medicines for Human Use (Clinical Trials) Regulations 2004 if that person was nominated by a Primary Care Trust or Strategic Health Authority.

---
Source: https://www.legislation.gov.uk/uksi/2013/235/schedule/3/paragraph/15 (the official version)
Page: https://openlegislation.uk/national-treatment-agency-abolition-and-the-health-and-social-care-act-2012-consequential-transitional-and-saving-provisions-order-2013/schedule-3/paragraph-15
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

